GLPG

#1997
Galapagos NV
28.7700 USD
+0.74%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
28.7600
29.0150
Year Range
27.9750
36.2200
Daily Change
+0.74%
Monthly Change
-10.82%
6 month change
-10.37%
Year Change
-10.37%
Previous Close
28.5600
Open
29.0150
Bid
Ask
Low
28.7600
High
29.0150
Volume
24
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.8959 B
  • Employee 452
  • Founded 1999
  • CEO Paul StoffelsPaul Stoffels
  • Website www.glpg.com
  • Headquarter Belgium
  • FIGI BBG000BJQY75
  • Industry Technology
Total debt
Free cash flow
Cash & equivalents

Galapagos NV - American Depositary Shares

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis.

News